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Abstract

THE REPORTING OF SUPPLEMENTS USE BY DENTAL PATIENTS ON THEIR
MEDICAL HISTORY QUESTIONNAIRE
by Sarmad Bakuri, DMD
A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science
in Dentistry at Virginia Commonwealth University.

Virginia Commonwealth University, 2014
Major Director: Thomas C. Waldrop, Professor, Director Graduate Periodontics, Department of
Periodontics

Objectives: The goals of the study were three fold. Estimate the prevalence of supplement use
by dental patients. Determine if the design of a medical history form influences the prevalence of
supplement use reported. Determine whether or not patients are aware of supplement side effects
and interactions with medications.

Methods: Patients were randomly allocated to either a standard medical history form or the same
form with additional questions about supplement use. After completing the initial forms, a
survey containing questions about supplements was filled out by both groups. For investigating
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differences between groups, logistic regression and analysis of variance were used depending on
the type of outcome variable.

Results: Two hundred and nine patients participated in the study. The mean number of
supplements reported by patients was influenced by the type of health history questionnaire
given to the patient. Specifically asking about supplements versus not asking at all resulted in
nearly double the number of supplements reported by the patient (mean of 1.53 when asked, 0.76
when not asked, p< 0.0001). Patient age and income were related to number of supplements
used per patient. The two oldest age categories (50–65 and >65) reported a mean number of
supplements used of 2.82 and 2.72, respectively versus the youngest age group (<30 years old)
which reported a mean of 1.05 (p<0.05). The highest income level (>$75,000 per year) reported
the lowest number of supplements per patient of 0.56 versus the other income levels (p<0.02),
which reported mean supplemental use ranging from 2.28 to 2.71. Additionally, the majority of
the subjects (69 %) were not aware of the side effects and interactions of supplements with
medications.

Conclusion: Patients tend not to report supplement use on the medical history questionnaire
unless they are directly asked and the majority of patients are not aware of interactions with
medications. Patient income and age have an effect on the frequency of supplement use.
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INTRODUCTION

Dietary supplements include products used to supplement the diet including herbs, vitamins,
minerals, and botanicals. 1 ’2 Supplements have been used in the medical field over the centuries
and the advantages of their use were reported in the Chinese and Indian books. Supplement use
evolved over the years in different parts of the world, and especially in the United States where
the use of supplements dramatically increased after the FDA made significant changes to the
regulation of dietary supplements in 1994.
The FDA used to regulate supplements under the category of food. In the past the FDA checked
and evaluated the supplements before they reached the market in order to ensure that they were
safe for consumption.3 In 1994 Congress passed the Dietary Supplement Health and Education
Act (DSHEA), thus establishing a totally new regulation for the use of dietary supplements.
Under the new regulation, the definition of “supplements” has been broadened, and supplements
are no longer subjected to the old evaluation procedures prior to reaching the market place. The
customer now depends solely on the manufacturer labels for safety. The truthfulness of
information written on the products label is subject to the discretion of the manufacturer. Under
the new law, after a supplement reaches the market the FDA can interfere only if it can prove
that it is not safe for use4 .

As a result of the DSHEA, the market share of dietary supplements has dramatically increased.
In addition to the DSHEA, the ease of use, the tendency of people to self-medicate, and the huge
1

effect that media has in promoting the use of supplements have cumulatively led to their
tremendous increase in sales. A survey done by the National Center for Health Statistics in 2006
5 6

’ found that 19% of US adults consumed supplements in 2002. This was nearly double the

amount reported in 1999, and the prevalence of their use jumped to 22% in 2006. Americans are
spending tremendous amounts of money on supplements. According to a review done by Glisson
and Crawford7 , Americans spent twelve billion dollars per year on medications. A third of these
dollars are spent on supplements. Sales of these products are steadily increasing by 15 % per
year. According to O’Hara8 one third of United States population uses supplements and spends
more than $3.5 billion annually, making the supplements market one of the fastest growing
businesses in the United States.
As the use of supplements in the US continues to grow, concerns about the safety of these
products have become an issue. The potential side effects of these products and the possible
interactions with conventional FDA-approved medications have been closely evaluated by the
medical society. These interactions may be additive, where the supplements increase the action
of the drug, or antagonistic, or decrease the action of the drug. Supplement and drug interactions
may result in either beneficial or adverse effects. The lack of adequate regulatory mechanisms
and the dramatic increase in the use of supplements, along with the low rate of reporting by
consumers, has given rise to serious concerns regarding their safety and efficacy. Therefore, a
large number of studies have evaluated the possible interactions of supplements with
conventional FDA approved drugs.

2

Many supplements interact with over the counter and prescribed medications. For example
aspirin and non-steroidal anti-inflammatory drugs (NSAIDS) are among the most utilized
medications in the United States for the treatment of mild and moderate pain9 . NSAIDS in
general, and aspirin specifically, decrease the synthesis of prostaglandin from arachidonic acid,
which affects the cyclooxygenase enzyme therefore decreasing inflammatory response. A
subsequent effect to that enzyme inhibition is interference with platelet aggregation. A survey of
the literature indicates that some supplements have antiplatelet and anticoagulant properties.

10 11
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Therefore, when patients use NSAIDs or aspirin along with supplements that induce antiplatelet
activity, there is an obvious increasing risk of bleeding in the stomach and elsewhere in the body.
In addition, some antiplatelet supplements have been reported to cause bleeding on their own
(i.e., in the absence of NSAIDs or any other drugs). Gingko, ginseng, garlic, and ginger are the
most common supplements that have been documented to possess antiplatelet activity, thus
having the potential to cause an even greater increase in the risk of bleeding when combined with
NSAIDs.

Patients get introduced to supplements through different routes including primary care
physicians, friends, family, and media promotion. However, most patients are not aware of the
potential side effects and drug interactions that these supplements may possess. According to
Eisenberg12 31% of the patients who use supplements do so in conjunction with prescribed
drugs, and 70% do not report the use of supplements to their physician. Patients generally do not
consider supplements as a medications and do not report their use of supplements to health care
provider13 .

3

The lack of adequate patient awareness, dramatic increases in the supplement use, along with the
serious documented side effects and drug interactions that these supplements may have, create
the need for a study to evaluate the use of supplements in dentistry. Most of the studies report the
prevalence of supplement use by patients in hospitals and physician clinics however, there are no
adequate studies on the use of these products by dental patients. The vast majority of the dental
information comes mainly from reviews and reports in the medical literature. Therefore, this
present study will look at: (1) the prevalence of supplement use by dental patients; (2) whether or
not patients report they are taking supplements on a medical history form; and(3) whether
patients that are taking supplements are aware of the possible side effects and interactions with
medications.

4

MATERIALS AND METHODS

Study design
Patient recruitment:
This study was reviewed by the Institutional Review Board at Virginia Commonwealth
University and received exempt status. Patients were recruited from the School of Dentistry
screening clinic at Virginia Commonwealth University (VCU). The purpose of this clinic is to
determine the suitability of the patients for treatment at the Virginia Commonwealth University
School of Dentistry clinics and is the initial visit to the clinics. Patients were randomly assigned
to two different health history forms A and B. Forms A and B contained the exact same
questions with the exact same sequencing except that form B had an additional question at the
very end asking patients if they use any supplements. (Attachment 2,3)
When patients returned the health history form they were asked to participate in a survey study.
Patients that agreed to participate in the study were given a three page survey form to fill out
(Attachment 1). The survey form had questions about patient’s demographic characteristics
including age, gender, race and education. The survey also asked additional questions about
current use of supplements.

No data were used from patients that decline participation in the

study.
All returned surveys were checked for completeness by the principle examiner (SB), and the
participating subjects were provided with a free, one day parking pass as an incentive for
5

participating in the study. Inclusion criteria included any patient older than 18 years who was
able to fill out the medical history form without aid of a parent or a caretaker.
Information (medical illnesses, current medications, and list of herbal supplements currently
used) from the health history form were transferred immediately to the survey form, and the
health history form was returned to the screening clinic. The survey was then entered into an
electronic database. No personally identifiable information was put in the database, thus the
research database was completely de-identified. The database was password protected and
maintained in such a manner that only study personnel had access.

Survey form Design:
The survey form collected information on the following:
●

Patient demographics: Patient’s age, gender, ethnicity, education level and income
level.

●

Patient’s herbal supplement use: Patients were asked in the survey whether they were
currently using herbal supplements. The patients who were using supplements were asked
(yes or no) to identify supplements that they were using from a list of 25 commonly used
supplements.(Table 1). Patients were also asked to provide a list of any additional
supplements that were taking that they were not on that list. The dosage and frequency of
use of each supplement was also collected.

●

Information related to herbal supplements use: This section includes three questions
that were related to the use of supplements. These questions included: (1) who
prescribed or recommended the herbal supplements? (2) did the patient report the use of
herbal supplements to their Dentist? (3) is the patient aware of possible complications
6

that may arise from the use of herbal supplements, and (4) is the patient aware of the
possible interactions between herbal supplements and certain prescribed medications
such as Warfarin, Plavix, Aspirin and Cyclosporine?
,
●

Information obtained from patient’s health history form: included patient’s medical
illnesses, current medications, and list of herbal supplements currently used.

Data analysis
Sample size justification
Power analysis was done to determine sample size, with a sample size of greater than a
100 per group, the study will have power of 78.6% to yield a statistically significant
result if the difference in proportions is 19% (specifically, 69% versus 50%). The study
will be able to test for smaller differences in continuous variables. Note that this is a pilot
study on this type of information, thus, once the actual variability of the data is
determined in the study more precise power analysis can be done.

7

Analysis
The goal of the study is to determine the knowledge of patients about supplements, the
frequency and completeness of patients reporting supplements and demographic factors
of subjects that are related to knowledge and reporting of supplement use.

The study utilized a tiered approach in collecting data. Two different medical histories
were utilized (randomly allocated to patients). One medical history form asked only for
information about use of medications. The second medical history explicitly asked for
supplements used by patients. Those patients who agreed to be subjects of the studies
were asked to list their supplement use by answering detailed questions about the specific
supplements used. Thus, both the extent of the reporting of supplement use reported in a
typical medically history form and the actual use of supplements were determined.

Demographic information on the subjects in this report was summarized as means +
standard deviation for continuous variables and percentages along with 95% confidence
intervals for categorical variables.

Testing for reporting or not reporting of supplement

between the two different types of medical histories was done by the chi square good
ness of fit test. Testing for the frequency of reporting (i. e. the actual number of
supplements reported per patient) between the three different methods of data gathering
(two medical histories and the survey) was done with analysis of variance with Tukey’s
test for multiple comparisons. Finally, for investigating demographic variables

8

influencing the extent of the report of supplements, logistic regression and analysis of
variance was used for the two different types of outcome variables.

9

RESULTS

Two hundred and nine patients participated in the study. Patients in group A and B who agreed
to participate in the study received an additional three page survey form after filling out their first
medical history form. This survey form asked participants to the best of their knowledge to list
all currently and previously taken herbal supplements. Then the participants were asked to
answer questions about supplements recommendations and their knowledge of possible side
effects and interactions caused by supplements use.
Of the individuals who agreed to participate in the study, 107 patients filled out form A (health
history form with a question about medications use only) and 102 patients filled out form B
(health history form with questions about medications and about supplements use). Five
hundreds and two refused to participate in the study. The two groups (A and B) were balanced on
the basis of race, age gender, education and income. When the two groups were evaluated there
were no statistical differences between groups A and B (Table 1).
There was a statistically significant difference in the number of reported supplements between
patients in group A and B. Patients in group A reported the mean supplement use per person of
0.76 versus 1.53 for group B (p value <0.05). In the survey form both reported even higher mean
3.1 for group A and 2.68 for group B (not statistically significant) (Table 2). Thus, patients
report more supplements use when using more extensive and detailed questions about
supplement use. This was clearly demonstrated when we compare the mean supplements
reported in form A (with no question about supplements ) to form B with one question about
10

supplements use and with the survey form that asked the patient to discuss the supplements use
in detail.
Patients had a low level of awareness about possible herbal supplements side effects and
interaction with other medications (Table 3). Seventy nine percent (165 patients) from both
groups were not aware of the possibility of increasing bleeding tendency as a side effect of
certain supplements usage. Seventy four percent of them were not aware of possible inactivation
of immune regulatory drugs by the use of (certain) supplements. A higher number of patients
(84%) were not aware of the possible nervous system depression that may arise from
supplements use and, finally, (69%) of the patients were not aware of the possible interaction of
certain herbal supplements with anti-clotting medications resulting in either an increased or
decreased effects of these medications.
Table 4 provides information on who recommended the use of supplements for patients in both
groups. Forty three percent of patients had physician recommendations for the use of
supplements, 12 % had recommendations from dentists and 22 % by family members. The
highest percentage 51% was due to self-recommendations. One percent of patients reported that
someone other than the listed categories recommended the supplements use, and one patient
wrote Dr. Oz as the person who recommend the supplements use.
Table 5 presents analyses on how demographics and other factors were related to supplement use
and/or how it is reported. Form type, comparing mean supplements reported in form A versus
form B (where patients were asked additional questions about supplement use), patients that
filled form B reported more mean supplements use than patients that filled form A (mean of 0.76
when patients were not asked about supplements usage {form A} versus 1.53 when asked about
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supplements{form B}). Patient age was related to the reported frequency of supplement use with
patients >65 years old having a mean supplement use of 2.83 versus 0.94 for patients <30 years
old. Patient income also had a statistically significant impact on supplements use with patients
with more >75K having a mean of 0.57 supplement use per patient versus patients <35K with a
mean of 2.37. This suggests that the financial affordability of supplements by high income
patients does not necessarily mean more supplement use. However, the sample size of the high
income patients was only 10 patients.

12

DISCUSSION

Our current study, to the best of our knowledge, is one of the first studies that has evaluated the
use of supplements in a dental school setting. The study provides evidence that patients reporting
the use of supplements was influenced by the type of health history questionnaire given to them.
The study agreed with the published articles about supplements used in the medical field in terms
of frequency of supplements use. The study that was done in Washington University by
Kennedy5 found that 38 million adults used supplements and Eisenberg12 , in a frequently quoted
national survey, reported a prevalence of herbal supplements use of 32-54% and varied based on
different demographic factors. The current study also agreed with studies in the medical field
that patients were not aware of possible side effects and interactions that may arise from the use
of supplements. Most published studies focused on reporting the patients’ feedback if the herbal
supplements are safe or not. Planta18 reported 86% of patients think that supplements are safe
and our study to the authors’ best knowledge is the first study to ask patients if they know the
specific side effects and interactions19 .
The data in the current study provided evidence that that patients with low socioeconomic status
(low income) used more supplements than patients from high socioeconomic status (high
income) which raises a question about the frequency of supplements use versus the affordability
and accessibility of supplements. Our results were in agreement with the Planta 18 study were
69% of low income people (less than $ 20,000) used supplements versus 14 % of people with
higher income. Our study showed that the highest income level (>$75,000 per year) reported the
13

lowest number of supplements per patient of 0.56 versus the other income levels that reported
mean supplemental use ranging from 2.28 (p<0.02). However, in our patient sample the high
income population was poorly represented with only 10 patients.
There was conflicting evidence about the use of supplements in different age groups. Our
results did not come in agreement with some studies like the Eisenberg

12

national survey where

patients aged 35-49 reported the highest percentage of supplement use (50%), followed by the
older group which reported (39%) and finally the younger group at (41%). In the current study
the two oldest age categories (50–65 and >65) reported a mean number of supplements used of
2.82 and 2.72 respectively versus the youngest age group (<30 years old) which reported a mean
of 1.05 (p<0.05). However our current results were in agreement with other studies that showed
that older Americans are consuming more supplements than other age groups.

20

The main issue regarding supplements that we are facing daily in clinic practice is that the
majority of patients don’t report the use of supplements. Heck
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found that 70% of patients fail

to report supplement use to their health care providers and they are not aware of possible
problems with the use of supplements.

Abebe21 discussed the various reasons for the lack of

reporting on the use of supplements. He suggested that most patients think that supplements are
not medications and thus are not reporting their use to health care providers.
Some supplements possess a list of serious and common interactions with most commonly taken
medications, especially the blood thinning medications. 22 In the current study, 79% of patients
were not aware of the possibility of increasing the bleeding tendency as a side effect of the use of
certain supplements. In addition, 74% of the patients were unaware of possible inactivation of
immune regulatory drugs with the use of certain supplements. A higher number of patients

14

(84%) were not aware of the possible nervous system depression that may arise from the use of
supplements. Finally, athough it has been shown by Norred 23 that 27% of surgical patients took
supplements that may inhibit coagulation, 69% of the patients in the current study were not
aware of the possible interaction of certain herbal supplements with anti-clotting medications.
While 43% of patients had physician recommendations for the use of supplements, 12 % had
recommendations from dentists and 22 % by family members. This was in agreement with other
studies were it was found that 22% of patients had friends recommendations and 19% had a
relative recommendation.

18

An additional interesting finding in the current study is that the

highest percentage of patients (51%) used supplements due to self-recommendations.
The most commonly used supplements by patients in our study were vitamins (which includes
Vitamin A,E,C,D and multi vitamins) followed by fish oil and calcium, The herbal supplement
echinacea was the most commonly used followed by ginseng and garlic. Most of published
studies had a similar list of top ten most frequently used supplements, and the current study
found very similar results to other studies, and in particular to the Mayo clinic study by Dergel19 .
Documented cases of life threating interactions arise from the unsupervised use of supplements,
which should elicit a major safety concern to health care providers. Planta found that 69% of the
health care providers lacked adequate education about supplements interactions and side effects.
18

A case report by Crowe24 demonstrated a relationship between taking large quantity of St. John’s
Wort and delayed emergence of the patient from general anesthesia. In addition, a report by
Rose25 described the occurrence of a spontaneous spinal epidural hematoma associated with
platelet mal function following ingestion of excessive amount of garlic supplements. Miller,11 in
15

a review article, proposed that potential hepatotoxicity may occur due to the prolong use of
echinacea. Finally, a documented case of Stevens- Johnson syndrome was reported by Dega26 in
a 27 years law student following 3 days of taking an unspecified amount of ginseng.
In a conclusion, the dramatic increase in supplement use in the United States,

12

the low rate of

patient reporting, and documented cases of serious side effects and drug interactions support the
need for enhancing medical history documentation of supplement use. Health care providers
should question all patients about the use of supplements and should be trained to identify the
potential side effects and serious interactions.

16
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Table 1: demographics of patients in study groups A and B

Form type

A

B

Femal

74

58

Male

32

41

White

72

53

Black

28

38

Others

7

11

<30

years old

14

17

>65

years old

19

18

30-40 years old

19

8

40-50 years old

16

16

50-65 years old

39

42

< $ 35,000

72

62

>$ 75, 000

4

6

20

22

$ 35,000 - $75,000

22

Table 2: Differences in mean number of supplements reported by patients in form A, B and
survey form

Medical history form difference
Form Type

number of

Mean

Std

patients

supplements

Err

Survey form difference
Mean

Std Err

reported
A(without supplement

107

0.76

0.12

3.1

0.28

102

1.53

0.16

2.68

0.2

question)
B(with supplement
question)

23

Table 3: Patients’ awareness of possible side effect of supplements and their interactions with
commonly prescribed medications

count

pts aware of

pts not aware of

interactions

interactions

Bledding

44

165(79%)

drugs

54

155(74%)

nervous system depression

34

175(84%)

65

144(69%)

inactivation of immune regulatory

interaction with blood thinning
medications
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Table 4: Most common sources of recommendation for supplements use to the patients

Sources of recommendation for supplements use
Count

# of patients and total Percentage

Dentist

26(12%)

Physician

90(43%)

Family

46(22%)

Self

105(51%)
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Table 5: Demographic factors that produces statistically significant impact on the mean of
supplements reporting

factor

mean

Age
pts>65 years old

2.83

pts<30 years old

0.94

Income
pts making < $ 35 k

2.37

pts making > $ 75 k

0.57

Medical history Form type
Form A with (w/out S question)

0.76

Form B with (w S question)

1.53
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Table 6: Most common used Non herbal and herbal supplements

Non Herbal Supplements
Fish Oil, Omega 3, or DHA Fatty Acid

78

Calcium

61

Vitamins (A,C,E)

41

Vitamin (B1-12)

36

Vitamin A,C,E

28

Multivitamin

24

Vitamin B1-B12

24

Vitamin D

21

Herbal supplements
Echinacea

15

Ginseng

14

Garlic pills or gelcaps

12

Melatonin

12

Saw palmetto

10
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Table 7: Most common supplements and their daily dosages, indications and possible
contraindications/drug interactions

14,15,16,17

Supplement

Daily Dosage

Usage indications

Contraindications and
possible drug interaction

Calcium

1000-1500 mg

Menopause
management, Bone
health

Extra caution should be
taken in patients with
Hyperparathyroidism and
Sarcoidosis

Ginger (Zingiber
officinalis) Root

Suggested daily dose
is 2 to 4 g is
recommended three
times a day.

Used as an antiemetic, prophylaxis
for travel sickness,
have an Antiinflammatory
properties.

Precautions should be
taken in individuals on
anticoagulants and/or
antiplatelet medications
(may increase chances of
bleeding)

Garlic
(Allium sativum)
Bulb

Suggested daily
dosage is 1.5-2 g of
garlic bulb per day or
400mg 3 times a day.

Garlic is popular for
its effect in reducing
various risks
associated with
cardiovascular
disease

Garlic have active
ingredients that has been
reported to inhibit
platelet aggregation.
Precautions should be
taken in individuals on
anticoagulants .

Ginkgo
(Ginkgo biloba)
Leaf

Suggested daily
dosage is 120 to 240
mg of dry extract
3 times a day.

Increase peripheral
blood flow; Ginkgo
has therapeutic effect
in treating the

Precautions should be
taken in individuals on
anticoagulants (may
increase chances of
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symptoms associated
with early stages of
Alzheimer’s disease

bleeding).
Also precautions should
be taken in individuals on
monoamine oxidase
(MAO) inhibitors as
ginkgo may alter the
effects of these
medications.

Ginseng (Panax)
(Panax ginseng) Root

Suggested daily
dosage is 1 to 2 g in
150 ml of water per
day.

Enhances the mental
and physical
capacities, Enhances
physical
performance;
increases energy.

Precautions should be
taken in individuals on
anticoagulants (may
increase chances of
bleeding).some
documented reports show
that It interact with
Warfarin.
Do not use in pregnancy.
Ginseng Abuse
Syndrome (GAS) may
occur in prolonged use.

Kava Kava
(Piper methysticum)
Root

Suggested daily
dosage is 100-250mg,
1-3 times

Kava is famous for its
sedative and
anxiolytic properties.
It is effective in
treating nervous
anxiety and stress.

Contraindicated in
patients with liver
disease or liver
impairment.
Also contraindicated in
patients with Parkinson’s
Disease (due to its effect
as dopamine
antagonism).
Precautions should be
taken in individuals on
anticoagulants.

Echinacea (Echinacea
purpurea) Flower,
whole plant, root

Suggested daily
dosage is 1 g cut root
several times daily or
500mg, 3 times a day

Echinacea have a
significant immune
stimulation properties
because of its effect

Not for use in individuals
with chronic
immunosuppression.
Use with caution in
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for 1day, then cut it
down to 250mg, 4
times a day.

Fish oil
(Eicosapentaenoic
acid)

the AHA recommends
a daily dosage of 1000
mg of EPA and DHA
omega 3s

on phagocytosis and
it enhances the
nonspecific T-cell
stimulation
Increasing nonspecific immunity;
used for the treatment
of flu, colds, and
tonsillitis.
Very well known for
its use in treating
Hypertriglyceridemia,

Suggested daily
dosage is 300mg, 3
times a day.

St. John’s Wort used
in the treatment of
psychological
disturbances and
depressive moods.
It is also used as a
topical agent for
bruises and muscle
soreness.

Devil’s claw

Suggested daily
dosage is 1.5 g per
day.

Analgesic, also it is
well known for its
use in weight
management since it
enhances loss of
appetite and weight
loss.

Suggested daily
dosage is 25-100mg,
1-3 times a day

Used in treatment of
allergies and asthma.
However it effect
coagulation by

Procumbens

Grape Seed
(Vitis vinifera)
Seed/skin

prophylaxis, cycle 3
weeks on, 1 week off

GI disturbances, bloating
and diarrhea.

and atherosclerosis

St. John's Wort
(Hypericum
perforatum)
Flowering buds

Harpagophytum

individuals with kidney
disorders.95
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Extreme cautions should
be taken when used with
medications metabolized
by the cytochrome P450.
Also precautions should
be taken in individuals on
monoamine oxidase
(MAO) inhibitors.
Dizziness, nausea, and
gastrointestinal upset.
Another side effect is
photosensitivity in
susceptible individuals.
Diarrhea, GI discomfort
and possible
arrhythmia, Precautions
should be taken in
individuals on
anticoagulants (may
increase chances of
bleeding).
Precautions should be
taken in individuals on
anticoagulants (may
increase chances of

Saw palmetto

1-2 g of cut fruit.

(Serenoa repens)

Peppermint (Mentha
piperita) Leaf/oil

Suggested daily
dosage is 1 tablet
(enteric coated), 2-3
times a day

Bromelain

Suggested daily
dosage is 80-320 mg
2-3 times daily

Feverfew

Suggested daily
dosage is 50 to 150
mg of dried leaves.

(Tanacetum
parthenium)

decreasing platelet
aggregation.

bleeding).

Urinary tract
infections(UTI).and
benign prostatic
hyperplasia.

Vomiting, nausea,
diarrhea,

Oil is used to treat
Irritable Bowel
Syndrome. Also it is
Well known for its
use as digestive aid.
Used to treat
autoimmune
Disorders,
Inflammation, OA,
and gout

Precautions should be
taken in patients with
biliary tract obstruction,
or severe liver damage.

used for treatment of
migraine and also as
prophylactic
treatment of
headaches.

GI discomfort, Oral
ulcers and allergic
reactions.
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and headache

Diarrhea, GI discomfort.
May prolong coagulation
and PT.

Attachment 1: Survey form

Department of Periodontics
Patient survey
Please circle the most appropriate answer in sections A,B and C
A1- Age:

less than 30

2- Gender:

3- Ethnicity:

30-40

male

white

Black

4- Education: High School

5- Income:

40-50

less than 35 K

50-65

more than 65

female

Hispanic

Asian

Associate Degree

35 K- 75K
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Others

College

more than 75K

BAre you currently taking any herbal supplements?

Yes

No

If the answer is yes please proceed to the following question, if the answer is No please skip to
section C

Please put a mark next to each

supplements you use and provide the dosage and frequency of taking if possible.
NAME OF HERBAL SUPPLEMENT

DOSAGE

Aspirin
Ginkgo biloba
Ginseng
Ginger pills or gelcaps
Garlic pills or gelcaps
St John’s wort
Green tea pills
Fish oil, Omega 3 or DHA fatty acids
Echinacea
Valerian
Saw palmetto
Kava kava
Prebiotics or probiotics
Grape seed extract
Coenzyme Q
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FREQUENCY

Valerian
Vitamins
Ephedra
Hawthorn
Melatonin
Cranberry pills or gelcaps
Others:
Others:
Others:

C1-Who prescribed or recommended herbal supplements to you?
Doctor
Dentist
Pharmacist
Friend
Self
Family member
Others (please specify) :
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2-Did you report the use of herbal supplements to your dentist?
YES

NO

3-Are you aware of any of the following possible complications that may arise from herbal
supplements use? Please mark it down

Increase risk of bleeding

YES

NO

Inactivating immune regulating drugs

YES

NO

Nervous system depression

YES

NO

Others (please specify):

4- Are they aware of possible interaction between herbal supplements and certain
prescribed medications like warfarin, plavix, aspirin and cyclosporine?

Yes

No
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This page to be completed by the researcher:

Medical illnesses:

Current medications

Herbal supplements:
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Attachme nt 2: Medical Histor y Reference Form A
 Dear Patient,

If you would be so kind as to provide us with the following information regarding your
medical history, it will help expedite your appointment (we will obtain a more
comprehensive record of your medical history at a later time).
Please list any medical allergies

List any conditions requiring pre- medications (heart murmur, joint/valve replacement)

Have you ever tested positive for hepatitis B or C and/or HIV? If so, please list which you
tested positive for, any when

____________________________________________________________________________________

37

List any overnight hospitalizations in the last ten (10) years ____________________________________

List any current medical conditions/diseases you have ________________________________________

List ALL current medications (name of med ication, dosage, frequency, and for what
reason you take it.

MEDICATION

DOSAGE

FREQUENCY

REASON FOR USE

__________________________________________________________________________________

__________________________________________________________________________________

__________________________________________________________________________________
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Attachme nt 3: Medical Histor y Reference Form B
 Dear Patient,

If you would be so kind as to provide us with the following information regarding your
medical history, it will help expedite your appointment (we will obtain a more
comprehensive record of your medical history at a later time).
Please list any medical allergies

List any conditions requiring pre- medications (heart murmur, joint/valve replacement)

Have you ever tested positive for hepatitis B or C and/or HIV? If so, please list which you
tested positive for, any when

____________________________________________________________________________________
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List any overnight hospitalizations in the last ten (10) years ____________________________________

List any current medical conditions/diseases you have ________________________________________

List ALL current medications (name of medication, dosage, frequency, and for what
reason you take it.

MEDICATION

DOSAGE

FREQUENCY

REASON FOR USE

__________________________________________________________________________________

__________________________________________________________________________________

__________________________________________________________________________________
List ALL current supplements (name of supplements, d osage, frequency, and for what
reason you take it.
SUPPLEMENT

DOSAGE
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FREQUENCY

REASON FOR USE

Figure 1: Patients distribution by income
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Figure 2: Patients distribution by age
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Figure 3: Patients distribution by gender
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Figure 4: Patients distribution by race
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